8-K: Nukkleus-Sponsored SPAC Files for $150M IPO

Nukkleus Inc. announced its indirect subsidiary, SC II Acquisition Corp. I, filed a registration statement for a proposed $150 million initial public offering of units.

Summary

• Nukkleus Inc. is the majority owner of the sponsor of SC II Acquisition Corp. I (SC II), a newly formed special purpose acquisition company (SPAC).
• SC II filed a registration statement on Form S-1 with the SEC on October 16, 2025, for a proposed initial public offering (IPO) of its units.
• SC II intends to raise $150 million in the proposed IPO through the sale of units.
• Each unit is expected to have an offering price of $10.00 and consists of one Class A ordinary share and one right to receive one-fifth (1/5) of a Class A ordinary share upon the consummation of an initial business combination.
• SC II also expects to grant the underwriters an option to purchase up to an additional $22.5 million of units.
• SC II intends to list its units on the Nasdaq Global Market under the symbol SCIIU.
• Menachem Shalom, the Chief Executive Officer of Nukkleus, is expected to serve as the Chief Executive Officer of SC II.
• D. Boral Capital LLC is acting as the book-running manager for the proposed IPO.

Sentiment

Score: 7

Explanation: The announcement of a corporate-sponsored SPAC IPO is generally a positive strategic move, indicating expansion and potential for future value creation for Nukkleus. However, the inherent risks associated with SPACs and the preliminary nature of the filing temper the overall sentiment.

Positives

• Nukkleus is expanding its strategic footprint by sponsoring a new Special Purpose Acquisition Company (SPAC), potentially creating new avenues for growth and value.
• The proposed IPO aims to raise $150 million, indicating a significant capital event for the new entity.
• Leveraging existing management, with Nukkleus CEO Menachem Shalom expected to lead SC II, suggests continuity and experienced leadership for the new venture.

Negatives

• There is no assurance that the proposed IPO of SC II will be completed on the terms described, within the expected timeframe, or at all.
• The completion of the proposed offering and any subsequent business combination process for SC II remain subject to market, legal, and regulatory conditions, introducing uncertainty.
• Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from expectations.

Risks

• There can be no assurance that the proposed offering of SC II will be completed on the terms described, within the expected timeframe, or at all.
• The completion of the proposed offering and the subsequent business-combination process remain subject to market, legal, and regulatory conditions.
• Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially.

Future Outlook

The future outlook includes the anticipated size, timing, structure, and success of the proposed IPO of SC II, the expected composition of its sponsor and management team, and the prospects of completing a future business combination. However, there is no assurance that the proposed offering will be completed on the terms described, within the expected timeframe, or at all, as it remains subject to market, legal, and regulatory conditions.

Management Comments

• Menachem Shalom, the Chief Executive Officer of Nukkleus, is expected to serve as the Chief Executive Officer of SC II Acquisition Corp. I.

Industry Context

The filing indicates Nukkleus is expanding its involvement in the financial markets by sponsoring a Special Purpose Acquisition Company (SPAC). This aligns with a broader trend where established companies or financial sponsors launch SPACs to capitalize on market opportunities for mergers and acquisitions, offering a potentially faster route to public markets for target companies compared to traditional IPOs.

Management Changes

Stakeholder Impact

• Shareholders of Nukkleus: Potential for increased shareholder value through the success of the sponsored SPAC, but also exposure to SPAC-related risks and the performance of SC II.
• Investors in SC II IPO: Opportunity to invest in a new SPAC, subject to the risks inherent in SPACs and the success of finding a suitable business combination.
• Management of Nukkleus: Menachem Shalom will take on an additional leadership role, potentially increasing workload and strategic focus across both entities.

Next Steps

• The registration statement for SC II's IPO needs to become effective with the SEC.
• SC II will proceed with the proposed IPO, including the sale of units.
• SC II intends to list its units on the Nasdaq Global Market under the symbol SCIIU.
• SC II will seek to complete an initial business combination following the IPO.

Key Dates

Recommendation

The filing announces a strategic expansion for Nukkleus through the sponsorship of a new SPAC and its proposed IPO. While this indicates potential for future value creation and diversification, the success of a SPAC IPO and its subsequent business combination is inherently uncertain and subject to market conditions. Given the preliminary nature of the announcement and the associated risks, a 'hold' recommendation is appropriate for existing Nukkleus shareholders to observe the execution and progress of SC II.

Keywords

SPAC, IPO, Nukkleus, SC II Acquisition Corp., Special Purpose Acquisition Company, Nasdaq, S-1, Registration Statement, Capital Raise